nanotech investing Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
nanotech investing Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
nanotech investing Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
nanotech investing Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
nanotech investing Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
New Report from KBR Supports Potential for US$1.75/kg Hydrogen from Syntholene's Geothermal-SOEC Platform
New Report from KBR Supports Potential for US$1.75/kg Hydrogen from Syntholene's Geothermal-SOEC Platform
Homerun Resources Inc. Confirms Optimized +4N Purification Plant Pathway and Advances CAPEX Configurations for the SME High-Purity Silica
Tartisan Nickel Corp. Completes Airborne MobileMTm and Borehole Em Geophysical Surveys at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario; Interpretation Underway
